0001217234-21-000087.txt : 20210504
0001217234-21-000087.hdr.sgml : 20210504
20210504185520
ACCESSION NUMBER: 0001217234-21-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210503
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maag Peter
CENTRAL INDEX KEY: 0001613855
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 21890437
MAIL ADDRESS:
STREET 1: CAREDX, INC.
STREET 2: 3260 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 1 TOWER PLACE
STREET 2: 9TH FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wf-form4_162016890334863.xml
FORM 4
X0306
4
2021-05-03
0
0001217234
CareDx, Inc.
CDNA
0001613855
Maag Peter
C/O CAREDX, INC.
1 TOWER PLACE, 9TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Executive Chair
Common Stock
2021-05-03
4
M
0
7375
12.24
A
420343
D
Common Stock
2021-05-03
4
M
0
7711
27.17
A
428054
D
Common Stock
2021-05-03
4
S
0
16952
76.4959
D
411102
D
Common Stock
2021-05-03
4
S
0
3048
77.4161
D
408054
D
Common Stock
1000
I
As UTMA custodian for minor child
Common Stock
1000
I
As UTMA custodian for minor child
Employee Stock Option (right to buy)
12.24
2021-05-03
4
M
0
7375
0
D
2028-06-29
Common Stock
7375.0
142625
D
Employee Stock Option (right to buy)
27.17
2021-05-03
4
M
0
7711
0
D
2029-02-04
Common Stock
7711.0
88289
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.005 to $77.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.02 to $77.83, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.
1/4th of the shares subject to the option vested on January 25, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter.
/s/ Peter Maag
2021-05-04